Ferric Oxide, Saccharated

erythropoietin ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31894555 Efficacy and safety of a low monthly dose of intravenous iron sucrose in peritoneal dialysis patients. 2020 Feb 1
2 19506383 Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone. 2009 1
3 19567093 [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study]. 2009 Feb 24 2
4 18212498 Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. 2008 1
5 16891647 Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. 2006 Oct 1
6 16431410 Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin. 2005 Dec 2
7 15363053 Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients. 2004 Aug 1
8 14607997 Intravenous iron as adjuvant therapy: a two-edged sword? 2003 Nov 1
9 17660651 Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. 2002 Apr-Jun 1
10 11134438 Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. 2001 Jan 1
11 11157370 Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. 2001 Feb 1
12 11262469 Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. 2001 Mar 1
13 11513178 Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. 2001 Aug 1
14 18212409 Maintenance intravenous iron therapy in hepmodialysis patients receiving recombinant human erythropoientin. 1999 Jan-Mar 2
15 7968018 Intravenous iron-sucrose complex to reduce epoetin demand in dialysis patients. 1994 Nov 5 1
16 1361844 A prospective open-label study evaluating the efficacy and adverse reactions of the use of Niferex-150 in ESRD patients receiving EPOGEN. 1992 1